# Tactile Medical to Release Second Quarter of Fiscal Year 2026 Financial Results on August 10, 2026
Canonical URL: https://biopharmsignal.com/news/TCMD/tactile-medical-to-release-second-quarter-of-fiscal-year-2026-financial-results--798d4004
Ticker: TCMD
Company: Tactile Systems Technology, Inc.
Source: Tactile Systems Technology, Inc.
Published: 2026-07-21 20:05 EST
Original Source URL: https://investors.tactilemedical.com/news-releases/news-release-details/tactile-medical-release-second-quarter-fiscal-year-2026
## Summary

The Investor Relations website contains information about Tactile Systems Technology, Inc. 's business for stockholders, potential investors, and financial analysts.

## Article Body
MINNEAPOLIS, July 21, 2026 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that second quarter of fiscal year 2026 financial results will be released after the market closes on Monday, August 10, 2026.

Management will host a conference call with a question and answer session at 5:00 p.m. Eastern Time on August 10, 2026, to discuss the results of the quarter. Those who would like to participate may dial 877-407-3088 (201-389-0927 for international callers) and provide access code 13761142. A live webcast of the call will also be provided on the investor relations section of the Company's website at investors.tactilemedical.com .

For those unable to participate, a replay of the call will be available for two weeks at 877-660-6853 (201-612-7415 for international callers); access code 13759535. The webcast will be archived at investors.tactilemedical.com .

About Tactile Systems Technology, Inc. (DBA Tactile Medical)

Tactile Medical is a leader in developing and marketing at-home therapies for people suffering from underserved, chronic conditions including lymphedema, lipedema, chronic venous insufficiency and chronic inflammatory lung disease by helping them live better and care for themselves. Tactile Medical collaborates with clinicians to expand clinical evidence, raise awareness, increase access to care, reduce overall healthcare costs, and improve the quality of life for tens of thousands of patients each year.

Investor Inquiries: Sam Bentzinger Gilmartin Group [email protected]
## Recent Company News
- 2026-07-21 20:05 EST — [Tactile Medical to Release Second Quarter of Fiscal Year 2026 Financial Results on August 10, 2026](https://biopharmsignal.com/news/TCMD/tactile-medical-to-release-second-quarter-of-fiscal-year-2026-financial-results--798d4004) — Source: Tactile Systems Technology, Inc.
- 2026-07-13 12:00 EST — [Tactile Medical Enters Exclusive U.S. Distribution Agreement with ElastiMed for its MyoSleeve™ Wearable Compression Device for VA and DoD Patients](https://biopharmsignal.com/news/TCMD/tactile-medical-enters-exclusive-u-s-distribution-agreement-with-elastimed-for-i-116aea64) — Source: Tactile Systems Technology, Inc.
- 2026-06-02 12:00 EST — [Tactile Medical Launches Next-Generation AffloVest® Airway Clearance Therapy](https://biopharmsignal.com/news/TCMD/tactile-medical-launches-next-generation-afflovestr-airway-clearance-therapy) — Source: Tactile Systems Technology, Inc.
- 2026-05-20 20:05 EST — [Tactile Medical to Present at the William Blair 46th Annual Growth Stock Conference](https://biopharmsignal.com/news/TCMD/tactile-medical-to-present-at-the-william-blair-46th-annual-growth-stock-conference) — Source: Tactile Systems Technology, Inc.
- 2026-05-04 20:05 EST — [Tactile Systems Technology, Inc. Reports First Quarter 2026 Financial Results](https://biopharmsignal.com/news/TCMD/tactile-systems-technology-inc-reports-first-quarter-2026-financial-results) — Source: Tactile Systems Technology, Inc.
## Related News
- 2026-07-21 20:15 EST — BFRG — [BullFrog AI to Participate in Water Tower Research Fireside Chat on Thursday, July 23, 2026](https://biopharmsignal.com/news/BFRG/bullfrog-ai-to-participate-in-water-tower-research-fireside-chat-on-thursday-jul-78357ce8)
- 2026-07-21 20:05 EST — CLPT — [ClearPoint Neuro to Announce Second Quarter 2026 Results August 3, 2026](https://biopharmsignal.com/news/CLPT/clearpoint-neuro-to-announce-second-quarter-2026-results-august-3-2026-6e4f3c05)
- 2026-07-21 20:05 EST — PIII — [P3 Health Partners Schedules Second Quarter 2026 Earnings Release and Conference Call](https://biopharmsignal.com/news/PIII/p3-health-partners-schedules-second-quarter-2026-earnings-release-and-conference-6c9bd8a7)
- 2026-07-21 12:05 EST — VRCA — [Verrica Pharmaceuticals and Medomie Pharma Enter into Exclusive Distribution, Marketing and Supply Agreement to Commercialize YCANTH® for the Treatment of Molluscum Contagiosum in Israel](https://biopharmsignal.com/news/VRCA/verrica-pharmaceuticals-and-medomie-pharma-enter-into-exclusive-distribution-mar-abf61522)
- 2026-07-21 11:30 EST — ABEO — [Cincinnati Children's Activated as the Seventh Qualified Treatment Center for ZEVASKYN®](https://biopharmsignal.com/news/ABEO/cincinnati-children-s-activated-as-the-seventh-qualified-treatment-center-for-ze-8382d043)